222 related articles for article (PubMed ID: 30604076)
41. Incidence and Risk Factors for Cholelithiasis After Bariatric Surgery.
Guzmán HM; Sepúlveda M; Rosso N; San Martin A; Guzmán F; Guzmán HC
Obes Surg; 2019 Jul; 29(7):2110-2114. PubMed ID: 31001756
[TBL] [Abstract][Full Text] [Related]
42. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy.
Venneman NG; Besselink MG; Keulemans YC; Vanberge-Henegouwen GP; Boermeester MA; Broeders IA; Go PM; van Erpecum KJ
Hepatology; 2006 Jun; 43(6):1276-83. PubMed ID: 16729326
[TBL] [Abstract][Full Text] [Related]
43. Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy.
Adams LB; Chang C; Pope J; Kim Y; Liu P; Yates A
Obes Surg; 2016 May; 26(5):990-4. PubMed ID: 26342481
[TBL] [Abstract][Full Text] [Related]
44. Gallstone Disease After Laparoscopic Sleeve Gastrectomy in an Asian Population-What Proportion of Gallstones Actually Becomes Symptomatic?
Hasan MY; Lomanto D; Loh LL; So JBY; Shabbir A
Obes Surg; 2017 Sep; 27(9):2419-2423. PubMed ID: 28401383
[TBL] [Abstract][Full Text] [Related]
45. Is routine cholecystectomy required during laparoscopic gastric bypass?
Villegas L; Schneider B; Provost D; Chang C; Scott D; Sims T; Hill L; Hynan L; Jones D
Obes Surg; 2004 Jan; 14(1):60-6. PubMed ID: 14980035
[TBL] [Abstract][Full Text] [Related]
46. Risk Factors for Cholecystectomy After Laparoscopic Roux-En-Y Gastric Bypass.
Haal S; Rondagh D; Hutten BA; Acherman YIZ; van de Laar AWJM; Huijgen R; Gerdes VEA; Voermans RP
Obes Surg; 2020 Feb; 30(2):507-514. PubMed ID: 31745862
[TBL] [Abstract][Full Text] [Related]
47. Role of Ursodeoxycholic Acid in the Prevention of Gallstones Formation in Bariatric Patients-a Systematic Review and Meta-Analysis of Randomised Trials.
Sharma A; Shanti H; Nageswaran H; Best LMJ; Patel AG
Obes Surg; 2023 Dec; 33(12):4115-4124. PubMed ID: 37872257
[TBL] [Abstract][Full Text] [Related]
48. Ursodeoxycholic acid in the prevention of gallstones in patients subjected to Roux-en-Y gastric bypass1.
Machado FHF; Castro Filho HF; Babadopulos RFAL; Rocha HAL; Rocha JLC; Moraes Filho MO
Acta Cir Bras; 2019 Feb; 34(1):e20190010000009. PubMed ID: 30785510
[TBL] [Abstract][Full Text] [Related]
49. Ursodeoxycholic Acid Use After Bariatric Surgery: Effects on Metabolic and Inflammatory Blood Markers.
Guman MSS; Haal S; Acherman YIZ; van de Laar AWL; Nieuwdorp M; Voermans RP; Gerdes VEA
Obes Surg; 2023 Jun; 33(6):1773-1781. PubMed ID: 37186289
[TBL] [Abstract][Full Text] [Related]
50. Effect of oral ursodeoxycholic acid on cholelithiasis following laparoscopic sleeve gastrectomy for morbid obesity.
Nabil TM; Khalil AH; Gamal K
Surg Obes Relat Dis; 2019 Jun; 15(6):827-831. PubMed ID: 31113752
[TBL] [Abstract][Full Text] [Related]
51. Concomitant cholecystectomy during laparoscopic sleeve gastrectomy.
Raziel A; Sakran N; Szold A; Goitein D
Surg Endosc; 2015 Sep; 29(9):2789-93. PubMed ID: 25480625
[TBL] [Abstract][Full Text] [Related]
52. Cholelithiasis after bariatric surgery, incidence, and prophylaxis: randomized controlled trial.
Talha A; Abdelbaki T; Farouk A; Hasouna E; Azzam E; Shehata G
Surg Endosc; 2020 Dec; 34(12):5331-5337. PubMed ID: 31858245
[TBL] [Abstract][Full Text] [Related]
53. Risk-Benefit Balance of Simultaneous Gastric Bypass or Sleeve Gastrectomy and Concomitant Cholecystectomy: A Comprehensive Nationwide Cohort of 289,627 Patients.
Marciniak C; Lenne X; Bruandet A; Hamroun A; Génin M; Baud G; Theis D; Pattou F; Caiazzo R
Ann Surg; 2023 Nov; 278(5):725-731. PubMed ID: 37476980
[TBL] [Abstract][Full Text] [Related]
54. The Management of Biliary Disease in Patients with Severe Obesity Undergoing Metabolic and Bariatric Surgery-An International Expert Survey.
Kermansaravi M; Shikora S; Dillemans B; Kurian M; LaMasters T; Vilallonga R; Prager G; Chiappetta S;
Obes Surg; 2024 Apr; 34(4):1086-1096. PubMed ID: 38400945
[TBL] [Abstract][Full Text] [Related]
55. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial.
Miller K; Hell E; Lang B; Lengauer E
Ann Surg; 2003 Nov; 238(5):697-702. PubMed ID: 14578732
[TBL] [Abstract][Full Text] [Related]
56. Ursodeoxycholic acid for the prevention of gallstone and subsequent cholecystectomy following gastric surgery: A systematic review and meta-analysis.
Choi JH; Lee SH; Cho IR; Paik WH; Ryu JK; Kim YT
J Hepatobiliary Pancreat Sci; 2021 May; 28(5):409-418. PubMed ID: 33768730
[TBL] [Abstract][Full Text] [Related]
57. Factors Affecting the Development of Gallstones Following Laparoscopic Sleeve Gastrectomy.
Özdaş S; Bozkurt H
Obes Surg; 2019 Oct; 29(10):3174-3178. PubMed ID: 31129884
[TBL] [Abstract][Full Text] [Related]
58. Gallstones and Bariatric Surgery: To Treat or Not to Treat?
Morais M; Faria G; Preto J; Costa-Maia J
World J Surg; 2016 Dec; 40(12):2904-2910. PubMed ID: 27412630
[TBL] [Abstract][Full Text] [Related]
59. Cholelithiasis and cholecystitis.
Schirmer BD; Winters KL; Edlich RF
J Long Term Eff Med Implants; 2005; 15(3):329-38. PubMed ID: 16022643
[TBL] [Abstract][Full Text] [Related]
60. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
Wudel LJ; Wright JK; Debelak JP; Allos TM; Shyr Y; Chapman WC
J Surg Res; 2002 Jan; 102(1):50-6. PubMed ID: 11792152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
